Skip to main content

Advertisement

Log in

Geographic hotspot detection for late-stage hepatocellular carcinoma: novel approach to cancer control

  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Importance

As hepatocellular carcinoma (HCC)-associated mortality continues to rise in the United States, there is a crucial need for strategies to shift diagnoses from late to early stage in order to improve survival.

Objective

To describe a population-based geospatial approach to identifying areas with high late-stage HCC burden for intervention.

Design

Cross-sectional study between 2008 and 2017.

Setting

Los Angeles County.

Participants

All incident cases of HCC with residential address at diagnosis in Los Angeles County were identified from a population-based cancer registry. Late stage included AJCC 7th Edition stages III–IV and unstaged cases.

Exposure

Sociodemographic factors.

Main outcome(s)

Geographic “hotspots” or areas with a high density of late-stage HCC, identified using kernel density estimation in ArcMap 10.3.1.

Results

51.8% of 7,519 incident cases of HCC were late stage. We identified a total of 23 late-stage hotspots, including 30.0% of all late-stage cases. Cases within hotspots were more often racial/ethnic minorities, foreign-born, under or uninsured, and of lower socioeconomic status. The age-adjusted incidence rate of late-stage HCC was twofold higher within hotspots (6.85 per 100,000 in hotspots vs 3.38 per 100,000 outside of hotspots). The calculated population-attributable risk was 43%, suggesting that a substantial proportion of late-stage HCC burden could be averted by introducing interventions in hotspot areas. We mapped the relationship between hotspots and federally qualified health centers primary care clinics and subspecialty clinics in Los Angeles County to demonstrate how clinic partnerships can be selected to maximize impact of interventions and resource use. Hotspots can also be utilized to identify “high-risk” neighborhoods that are easily recognizable by patients and the public and to facilitate community partnerships.

Conclusion and relevance

Reducing late-stage HCC through geographic late-stage hotspots may be an efficient approach to improving cancer control and equity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the Los Angeles County Cancer Surveillance Registry. The data are not publicly available due to restrictions from the registry as they contain information that could compromise confidentiality of cancer patients.

Abbreviations

AAIR:

Age-adjusted incidence rate

AJCC:

American Joint Committee on Cancer

API:

Asian Pacific Islander

FQHC:

Federally Qualified Health Center

GI/HEP:

Gastroenterology and hepatology

HCC:

Hepatocellular carcinoma

LAC:

Los Angeles County

LACSP:

Los Angeles Cancer Surveillance Program

PAR:

Population-attributable risk

SES:

Socioeconomic status

US:

United States

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  PubMed  Google Scholar 

  2. American Cancer Society (2019) Liver Cancer Survival Rates. https://www.cancer.org/cancer/liver-cancer/detection-diagnosis-staging/survival-rates.html. Accessed 28 Oct 2020

  3. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ (2010) Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg 145(12):1158–1163

    Article  PubMed  Google Scholar 

  4. Livraghi T, Meloni F, Di Stasi M et al (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47(1):82–89

    Article  PubMed  Google Scholar 

  5. Kim WR, Lake JR, Smith JM et al (2019) OPTN/SRTR 2017 Annual Data Report: liver. Am J Transplant 19(Suppl 2):184–283

    Article  PubMed  Google Scholar 

  6. Singal AG, Tiro JA, Marrero JA et al (2017) Mailed outreach program increases ultrasound screening of patients with cirrhosis for hepatocellular carcinoma. Gastroenterology. 152(3):608–615

    Article  PubMed  Google Scholar 

  7. Aby ES, Winters AC, Lin J et al (2020) A telephone and mail outreach program successfully increases uptake of hepatocellular carcinoma surveillance. Hepatol Commun 4(6):825–833

    Article  PubMed  PubMed Central  Google Scholar 

  8. Baicker K, Chandra A, Skinner JS (2005) Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med 48(1 Suppl):S42-53

    Article  PubMed  Google Scholar 

  9. Carlos HA, Shi X, Sargent J, Tanski S, Berke EM (2010) Density estimation and adaptive bandwidths: a primer for public health practitioners. Int J Health Geogr 9:39

    Article  PubMed  PubMed Central  Google Scholar 

  10. DATA USA (2020) Los Angeles County, CA. https://datausa.io/profile/geo/los-angeles-county-ca. Accessed 22 Oct 2020

  11. White DL, Thrift AP, Kanwal F, Davila J, El-Serag HB (2017) Incidence of hepatocellular carcinoma in all 50 United States, from 2000 through 2012. Gastroenterology 152(4):812–820

    Article  PubMed  Google Scholar 

  12. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474

  13. De SMJ, Goodchild MF, Longley P (2007) Geospatial analysis: a comprehensive guide to principles, techniques and software tools. Matador, Leicester

    Google Scholar 

  14. Gibin M, Longley P, Atkinson P (2007) Kernel density estimation and percent volume contours in general practice catchment area analysis in urban areas. Paper presented at Proceedings of Geographical Information Science Research Conference

  15. Lichtensztajn DY, Giddings BM, Morris CR, Parikh-Patel A, Kizer KW (2017) Comorbidity index in central cancer registries: the value of hospital discharge data. Clin Epidemiol 9:601–609

    Article  PubMed  PubMed Central  Google Scholar 

  16. Yang JSC, Harrati A, Clarke C, Keegan THM, Gomez SL (2014) Developing an area-based socioeconomic measure from American Community Survey data. Cancer Prevention Institute of California, Fremont

    Google Scholar 

  17. Yost K, Perkins C, Cohen R, Morris C, Wright W (2001) Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12(8):703–711

    Article  CAS  PubMed  Google Scholar 

  18. Mapping LA Neighborhoods (2020) Los Angeles Times. http://maps.latimes.com/neighborhoods/. Accessed 12 Aug 2020

  19. United States Census Bureau (2010) Census. U.S. Census Bureau. http://www.census.gov/data/tables.html. Published 2010. Accessed 1 Feb 2020

  20. United States Census Bureau (2000) Census. U.S. Census Bureau. http://www.census.gov/data/tables.html. Published 2000. Accessed 1 Feb 2020

  21. United States Census Bureau. TIGER/Line Shapefiles. https://www.census.gov/geo/maps-data/data/tiger-line.html. Published 2010. Accessed 1 Feb 2020

  22. Andrilla CHA, Moore TE, Man Wong K, Evans DV (2019) Investigating the Impact of Geographic Location on Colorectal Cancer Stage at Diagnosis: A National Study of the SEER Cancer Registry. J Rural Health. 36(3):316

    Article  PubMed  Google Scholar 

  23. Altekruse SF, Petrick JL, Rolin AI et al (2015) Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States. PLoS One. 10(3):e01250574

    Google Scholar 

  24. Rich NE, Hester C, Odewole M et al (2019) Racial and ethnic differences in presentation and outcomes of hepatocellular carcinoma. Clin Gastroenterol Hepatol. 17(3):551–559

    Article  PubMed  Google Scholar 

  25. Artinyan A, Mailey B, Sanchez-Luege N et al (2010) Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 116(5):1367–1377

    Article  PubMed  Google Scholar 

  26. Nathani P, Gopal P, Rich N et al (2021) Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis. Gut 70(2):401–407

    CAS  PubMed  Google Scholar 

  27. Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68(2):723–750

    Article  PubMed  Google Scholar 

  28. Singal AG, Yopp A, Skinner CS, Packer M, Lee WM, Tiro JA (2012) Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med 27(7):861–867

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gorin SS, Badr H, Krebs P, Prabhu DI (2012) Multilevel interventions and racial/ethnic health disparities. J Natl Cancer Inst Monogr 2012(44):100–111

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kerns K, Locklear L. Three New Census Bureau Products Show Domestic Migration at Regional, State, and County Levels. United States Census Bureau. https://www.census.gov/library/stories/2019/04/moves-from-south-west-dominate-recent-migration-flows.html. Published 2019. Accessed 8 Nov 2019

  31. Moon AM, Singal AG, Tapper EB (2020) Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 18(12):2650–2666

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by a University of Southern California Research Center for Liver Diseases grant 5P30DK048522 to Dr. Zhou. This work was also supported in part by the Population Research Core of the USC/Norris Comprehensive Cancer Center funded by the National Cancer Institute grant P30CA014089. The collection of cancer incidence data used in this study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s (CDC) National Program of Cancer Registries, under cooperative agreement 5NU58DP003862-04/DP003862; the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the author(s) and do not necessarily reflect the opinions of the State of California, Department of Public Health, the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors. The funders/sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Contributions

KZ is the guarantor of the article and all authors approved the final version of the manuscript. The authors made the following contributions: Concept and design: KZ, LT, and MC. Acquisition, analysis, or interpretation of data: KZ, LT, and MC. Statistical analysis: LT and MC. Drafting of the manuscript: KZ. Critical revision of the manuscript for important intellectual content: All authors.

Corresponding author

Correspondence to Kali Zhou.

Ethics declarations

Conflict of interest

Dr. Zhou and Dr. Terrault report institutional grant support from Gilead Sciences. The other authors report no disclosures.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 6445 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, K., Thompson, L.K., Liu, L. et al. Geographic hotspot detection for late-stage hepatocellular carcinoma: novel approach to cancer control. Cancer Causes Control 33, 701–710 (2022). https://doi.org/10.1007/s10552-022-01555-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-022-01555-0

Keywords

Navigation